What’s Fueling Generation Bio Co (GBIO) Stock’s -61.35% Loss Below Its 200-Day SMA?

TD Cowen has recently reduced Generation Bio Co (GBIO) stock to Market Perform rating, as announced on October 19, 2023, according to Finviz. Earlier, on November 8, 2022, Canaccord Genuity had initiated the stock to Buy, setting a price target of $9. William Blair also reduced Mkt Perform rating. Additionally, JMP Securities initiated Mkt Outperform rating on June 8, 2021, with a target price of $40. William Blair analysts, in their report published on February 24, 2021, also initiated Outperform rating for Generation Bio Co’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.

Generation Bio Co (GBIO) Stock Trading Recap

On Friday, Generation Bio Co (GBIO) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.96 and touched a low of $0.94 during the day, reaching a high of $1.02. The volume of shares traded was 0.93 million exceeding the average volume of 0.36 million.


Sponsored

GBIO Stock Performance and Moving Averages

In recent trading, Generation Bio Co (GBIO) stock price has shown some volatility, fluctuating 2.43% over the last five trades and -18.28% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -66.38%, and it has plunged by -61.46% in the previous three months. Currently, GBIO is trading at -8.04%, -29.18%, and -61.35% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.

As of the latest trading close, GBIO, a Healthcare sector stock, is trading -79.61% below its 52-week high but remains 26.40% above its 52-week low. The Average True Range (ATR) (14 days) of 0.13 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.

Generation Bio Co’s Profitability and Valuation Ratios

Generation Bio Co’s profitability metrics reveal financial health. The company currently boasts an operating margin of -485.50% and a profit margin of -782.87%, with a gross margin of -66.38%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.

In terms of valuation, Generation Bio Co’s market capitalization stands at $63.32 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Sales Ratio is 3.41, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 0.61, comparing the market value to the company’s book value.

Understanding Insider Trading

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 36.57% of Generation Bio Co (GBIO)’s shares, while financial institutions hold 66.05%.

Related Posts

Unlock Your Investment Potential: Get Your 100% Free eBook

Best Space Stocks To Buy

A detailed analysis of Three Best Space Stocks to Buy, each selected based on Innovations, Growth Metrics & Achievements

No thanks

Best Space Stocks to Buy!

Unlock Your Investment Potential: Get Your 100% Free eBook

A Detail Analysis of Three Best Space Stocks to Buy, Eash Selected Based on Innovations, Growth Metrics & Achievements